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Catalysis of amorpha-4,11-diene 
synthase unraveled and improved 
by mutability landscape guided 
engineering
Ingy I. Abdallah, Ronald van Merkerk, Esmée Klumpenaar & Wim J. Quax  
Amorpha-4,11-diene synthase (ADS) cyclizes the substrate farnesyl pyrophosphate to produce amorpha-
4,11-diene as a major product. This is considered the first committed and rate-limiting step in the 
biosynthesis of the antimalarial artemisinin. Here, we utilize a reported 3D model of ADS to perform 
mutability landscape guided enzyme engineering. A mutant library of 258 variants along sixteen 
active site residues was created then screened for catalytic activity and product profile. This allowed 
for identification of the role of some of these residues in the mechanism. R262 constrains the released 
pyrophosphate group along with magnesium ions. The aromatic residues (W271, Y519 and F525) stabilize 
the intermediate carbocations while T296, G400, G439 and L515 help with the 1,6- and 1,10-ring closures. 
Finally, W271 is suggested to act as active site base along with T399, which ensures regioselective 
deprotonation. The mutability landscape also helped determine variants with improved catalytic activity. 
H448A showed ~4 fold increase in catalytic efficiency and the double mutation T399S/H448A improved 
kcat by 5 times. This variant can be used to enhance amorphadiene production and in turn artemisinin 
biosynthesis. Our findings provide the basis for the first step in improving industrial production of 
artemisinin and they open up possibilities for further engineering and understanding of ADS.
Amorpha-4,11-diene synthase (ADS) is an enzyme attracting world-wide interest as it is a sesquiterpene synthase 
that catalyzes the conversion of farnesyl pyrophosphate (FPP) to amorpha-4,11-diene, which is the precursor for 
the important antimalarial artemisinin. The first line treatment for malaria, as recommended by the World Health 
Organization (WHO), is Artemisinin-based Combination Therapy (ACT)1,2. Interestingly, this valuable antima-
larial natural product in the past decade also gained massive attention for its anticancer properties3–5. Artemisinin 
is cytotoxic to cancer cells because its endoperoxide bridge interacts with iron producing free radicals that dam-
age proteins and kill the cells6,7, which leads to an increasing demand for artemisinin and derivatives. Improved 
and sustainable methods for production including biosynthesis and semi-synthesis have been developed to over-
come the problem of its low natural production6,8. ADS catalyzes the first and rate-limiting step in artemisinin 
biosynthesis7,9. Hence, it is important to study the structure of ADS to shed light on the involvement of the active 
site residues in the catalytic mechanism and create ADS variants with higher catalytic activity compared to the 
wild type.
Enzyme engineering to alter product specificity, thermostability and catalytic efficiency has been reported 
for a variety of classes of enzymes including terpene synthases. A thermostable mutant of 5-epi-aristolochene 
synthase has been reported10. Mutagenesis of the plasticity residues of γ-humulene synthase led to the generation 
of seven active synthases that produce different products11. As for amorphadiene synthase, the ads gene has been 
characterized12 and the enzymatic properties of ADS have been investigated13,14. In addition, a 3D model of ADS 
based on the 80% identical α-bisabolol synthase was created. The position of the co-factor magnesium ions and 
FPP substrate in the active site was established and verified15. The generation of mutability landscapes where a 
large number of protein variants are screened to discover the effect of each single amino acid substitution on 
enzyme activity, stability, and/or, selectivity is a valuable tool of protein engineering16. These landscapes produce 
detailed maps of favorable, neutral, and detrimental amino acids for each residue position in relation to different 
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enzyme properties. This offers vital information on sequence-function relationships by highlighting functionally 
important residues and hotspot positions important for catalysis16–19. In this paper, we selected sixteen active site 
residues to create a mutability landscape of ADS. This mutability landscape is screened for catalytic activity and 
product profile to determine the residues involved in the mechanism of ADS and to select variants with enhanced 
catalytic activity compared to the wild type with the aim of improving the overall production of artemisinin. 
Finally, as a proof of concept, in E. coli the amount of amorphadiene produced by the highly active variants was 
compared to that of the wild type ADS.
Results
Selection of residues for site-saturation mutagenesis. The ADS model previously reported15 was 
used to examine active site residues and determine the best candidates for mutation. Residues within 5 Å radius 
of the FPP substrate in the active site were considered followed by computational examination of their location 
in relation to surrounding active site residues and predicted protein-substrate interactions. Based on further 
examination of reports on other enzymes of the terpene synthases family, residues corresponding to the metal 
ion binding motifs were disregarded, as their mutation usually results in loss of activity. In addition, the type of 
interactions between the residues and the substrate, bond distances and literature reports about the significance of 
corresponding residues in other terpene synthases were taken in consideration. It has been reported that aromatic 
residues play an important role in stabilization of the carbocation intermediates. Also, histidines are candidates to 
be the catalytic base in the active site essential for deprotonation and reprotonation while arginines were reported 
to participate in constraining the released pyrophosphate. Based on all that information, sixteen residues were 
selected for mutation namely, R262, W271, T296, H392, V396, T399, G400, G439, R440, H448, K449, L515, 
Q518, Y519, D523, and F525.
Creation of ADS mutant library. To create the mutability landscape of ADS, an assortment of genes 
encoding possible variants of the selected residues was constructed. The typical use of NNN or NNS(K) degen-
erate codons during site saturation mutagenesis leads to codon redundancy, amino acid biases and generation 
of stop codons which decrease the quality of the library20. Hence, the strategy that uses a set of four degenerate 
codons; NDT, VMA, ATG, and TGG excluding the rare codons of E. coli and avoiding amino acid biases, was 
applied. Compared to the usual NNN or NNS(K), sequencing of 50 colonies per mutated residue produced a 
library with no rare or stop codons and with all amino acids represented equally. 95% of the sequenced mutants 
showed no deletions or undesired mutations. Approximately 85% of the desired mutants were obtained and all 
chemical groups of amino acids where present in the library. The missing mutants do not have significant impact 
on the quality of the library. This method is easy and fast where it allowed the generation and sequencing of a 
high quality library within one to two weeks21,22. A library in the total size of 258 variants was created. Finally, the 
library was purified and the concentrations of the variants were determined from the digital images of stained 
SDS gels (Fig. S1) using quantitative densitometric assay17. The landscape in Fig. 1 shows the expression levels of 
the different variants in the Library compared to the wild type.
Mutability landscape of ADS for catalytic activity. A mutability landscape for the catalytic activity of 
ADS was generated by examining the effect of each mutation on the production of amorpha-4,11-diene using 
two different assays. ADS converts the substrate FPP to amorpha-4,11-diene releasing inorganic pyrophosphate 
(PPi) in the process. The first assay depends on the fact that the amount of pyrophosphate released is equivalent to 
the amount of amorpha-4,11-diene produced. A rapid bioluminescent assay was used to measure the amount of 
pyrophosphate released continuously during the ADS reaction with FPP (Fig. S2), which is expressed as Relative 
Light Units (RLUs). The amount of light produced is directly proportional to the amount of PPi released during 
the reaction23. A curve of RLUs versus time is produced for all variants along with wild type ADS using the same 
concentration of protein and FPP (Fig. S3), where the slope of the linear part represents catalytic rate of reaction 
(V) as RLUs/sec for each sample. Hence, a mutability landscape comparing the catalytic activity of the wild type 
to the variants was generated (Fig. 2a). Variants with the darkest blue color in the landscape showed complete loss 
of enzyme activity whereas variants showing shades of red color indicated increase of activity compared to the 
wild type. The second assay was performed using GC-MS. Similar to the bioluminescent assay, a curve of amor-
phadiene peak area versus time is produced for each sample (Fig. S4), where the slope of the linear part represents 
the catalytic rate of reaction (V) as amorphadiene peak area/sec for each sample. Consequently, a mutability 
landscape based on the GC-MS assay was generated and compared to that produced from the bioluminescent 
assay (Fig. 2b).
The mutability landscapes showed that most variants of residues R262, W271, T296, G400, G439, R440, Y519, 
D523 and F525 completely lost their activity indicating that these residues play an essential role in ADS mech-
anism, which will be further explored in the 3D model to designate their function. In addition, some variants 
of residues H392, V396, T399, H448, K449 and Q518 demonstrated catalytic activity higher than the wild type. 
The position with the highest impact on catalytic activity is H448 where 15 of the variants improved the catalytic 
activity. The next step in screening the library would be examining the product profile compared to the wild type 
and linking it to the catalytic activity.
Evaluation of the product profile of the ADS library using GC-MS. Following the screening of the 
library for catalytic activity, the GC-MS product profile of the library was compared to that of wild type ADS. 
Wild type ADS produces amorpha-4,11-diene as major product along with other sesquiterpenes as minor prod-
ucts as shown in its GC chromatogram (Fig. S5). The GC chromatograms of the variants in the library were com-
pared to that of the wild type. Inactive variants showed no products at all in their GC chromatograms (Fig. S6) 
confirming their inactivity in the mutability landscape for catalytic activity. Residue L515 was found essential for 
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product specificity of ADS as its mutation changed the product profile by decreasing the amount of amorpha-
diene produced and increasing the amount of γ-humulene or α-bisabolol. In addition, T296L and T296Y were 
found to produce the acyclic β-farnesene suggesting that they are unable to perform the cyclization step in the 
mechanism, similar as reported before for T296I and T296V24.
Role of selected active site residues in the mechanism of ADS. ADS is a cisoid sesquiterpene syn-
thase where its mechanism (Fig. 3) begins with an isomerization step at the Δ2,3 double bond of (2E,6E)-FPP 
followed by ionization to produce (2Z,6E)-farnesyl cation. The farnesyl cation undergoes 1,6-ring closure to give 
a bisabolyl cation. The next step is hydride shift in the bisabolyl cation and 1,10-cyclization to create the amorphe-
nyl cation. Deprotonation at C-12 or 13 of the amorphenyl cation leads to the production of amorpha-4,11-diene 
as the major product. ADS can also produce minor amounts of other sesquiterpenes from side reactions along 
the pathway. Based on the mutability landscape of ADS for catalytic activity and the screening of product profile 
of the library, the involvement of certain residues can be deduced. Hence, residues that are essential for the mech-
anism were determined and their role explained as follows.
The sequence of ADS was aligned with several monoterpene and sesquiterpene synthases (Figs 2c and S8) 
to spot the similarities and differences between them to provide a picture about the involvement of different 
residues in the mechanism. Among these sesquiterpene synthases are α-bisabolol synthase, 5-epi-aristolochene 
synthase, germacrene A synthase, β-cayophyllene synthase, α-humulene synthase, γ-humulene synthase, 
epi-cedrol synthase, aristolochene synthase, δ-cadinene synthase and β-farnesene synthase along with the mono-
terpene synthases: limonene synthase, 1,8-cineole synthase and bornyl diphosphate synthase. β-farnesene syn-
thase lacks cyclization and produces the acyclic sesquiterpene β-farnesene. α-bisabolol synthase performs only 
1,6-cyclization to create the monocyclic α-bisabolol while germacrene A synthase just does 1,10-ring closure to 
generate the monocyclic germacrene A. Epi-cedrol synthase is another sesquiterpene synthase from Artemisia 
annua like ADS. The enzymes α-humulene and γ-humulene synthase execute 1,11-cyclization to produce their 
major product. δ-cadinene synthase is a cisoid sesquiterpenes synthase as ADS but with slightly different ring 
cyclizations. Aristolochene synthase is also a cisoid sesquiterpene synthase that performs an initial 1,10-ring 
cyclization followed by 1–6, ring closure. 5-epi-aristolochene synthase is a transoid sesquiterpene synthase that 
does not carry out the initial isomerization step and produces 5-epi-aristolochene as its major product25–29. 
Figure 2c shows, among the sixteen residues in the mutability landscape, those that are identical, strongly simi-
lar, weakly similar and non-matching compared to ADS. The position of the sixteen residues in the active site is 
highlighted in Fig. 3a.
Residues involved in constraining the released pyrophosphate in the active site. The arginine and lysine residues 
(R262, R440 and K449) located in the active site of ADS within 4 Å of the substrate are present in the protonated 
Figure 1. Mutability landscape of ADS for expression level using quantitative densitometric assay. For the 
mutability landscape, the vertical axis portrays the 20 possible amino acid residues. The wild-type amino acid 
residue at each position is indicated by bold squares, white squares represent variants that are not present in 
the library and grey squares represent variants that are not expressed. The color represents the concentration 
of expressed protein where blue range squares indicate decrease in expression while red range squares indicate 
increase in expression compared to the wild type.
www.nature.com/scientificreports/
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form carrying a positive charge so they cannot act as the active site base. However, they can play a role in con-
straining the PPi moiety released from the substrate (Fig. 3b), where these residues along with the magnesium 
ions may bind the negatively charged PPi group to prevent it from recapturing the formed reactive carboca-
tions9,30,31. ADS variants of R262 including R262K showed loss of catalytic activity indicating its important role 
in restricting the PPi group. It is noteworthy to mention that due to the guanidinium group of arginine, it can 
perform a larger number of interactions compared to lysine32. Hence, the R262K variant was inactive. It was 
hypothesized that R264 and R441 of 5-epi-aristolochene synthase (5-EAS) perform this role30. Thus, it was sug-
gested that R262 and R440 in ADS corresponding to those in 5-EAS would act similarly9. However, R440A, R440S 
and R440T show very low activity, in addition, the side chain of R440 is pointing away from the active site with 
more than 10 Å bond distance separating it from the PPi. The situation is similar with the R440 in the crystal 
structure of α-bisabolol synthase (BOS). By examining the crystal structure of 5-EAS, it is clear that the side chain 
of R441 is directed towards the active site unlike ADS and BOS but the bond distance was still too big to allow 
for interaction with the PPi. Finally, K449 variants retained their activity so it does not seem to be involved with 
Figure 2. (a) Mutability landscape of ADS for catalytic activity using bioluminescent assay. (b) Mutability 
landscape of ADS for catalytic activity using GC-MS assay. For the mutability landscapes, the vertical axis 
portrays the 20 possible amino acid residues. The wild-type amino acid residue at each position is indicated 
by bold squares, white squares represent variants that are not present in the library and grey squares represent 
variants that are not expressed. The color represents the catalytic rate of reaction (V) where blue range squares 
indicate decrease in catalytic activity while red range squares indicate increase in catalytic activity compared 
to the wild type. The illustrated data are an average of two separate experiments (n = 2). (c) Multiple sequence 
alignment of the mutability landscape of ADS with ten sesquiterpene synthases and three monoterpene 
synthases. Residues that are identical, strongly similar, weakly similar and non-matching compared to ADS are 
colored dark blue, blue, cyan and white, respectively.
www.nature.com/scientificreports/
5SCIentIfIC RepoRts |  (2018) 8:9961  | DOI:10.1038/s41598-018-28177-4
this function. It can be concluded that only R262, along with the magnesium ions, are responsible for binding the 
PPi group and directing it away from the carbocations in the active pocket. Furthermore, R262 is conserved in 
several monoterpene and sesquiterpene synthases (Fig. 2c). Also, R440 is conserved which might indicate that it 
has another role in the mechanism but not this one.
Aromatic residues play an essential role in the mechanism. The vital role of aromatic residues in stabilizing the 
carbocation intermediates in the active site of sesquiterpene synthases is discussed in literature15,31,33,34. Amid 
the aromatic residues lining the active site of ADS, three residues (W271, Y519 and F525) are within 3 Å radius 
of the substrate with their phenyl rings angled towards the active site showing π-alkyl interactions with the sub-
strate (Fig. 3c). By examining the mutability landscape of ADS, all variants of these residues showed no catalytic 
activity in the bioluminescent assay and no products in their GC-MS chromatograms indicating loss of enzyme 
activity except for F525Y which retained low activity. This proves the essential role of these aromatic residues in 
the mechanism where they can stabilize the intermediate carbocations until production of amorpha-4,11-diene. 
In addition, sequence alignment of ADS along with several sesquiterpene and monoterpene synthases (Fig. 2c) 
showed that these aromatic residues are conserved.
Residues involved in 1,6- and/or 1,10 ring closure. ADS mechanism involves two ring closures, first is 1,6-closure 
to produce bisabolyl cation followed by 1,10-closure to produce amorphenyl cation. It has been reported that 
Figure 3. Proposed mechanism of ADS. (a) The substrate (2E, 6E)-FPP in the active site surrounded by the 
sixteen residues selected for mutation. (b) Following isomerization, the intermediate (2Z, 6E)-Farnesyl cation 
(green) and the released pyrophosphate (red) are in the active site. (c) 1,6-ring closure leads to the formation 
of the bisabolyl cation. (d) 1,10-ring closure produces the amorphenyl cation. (e) Deprotonation at C-12 or 13 
creates the final product amorpha-4,11-diene.
www.nature.com/scientificreports/
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T296V lost its cyclization ability producing the acyclic β-farnesene instead of amorpha-4,11-diene24,35. T296L and 
T296Y showed the same pattern of behavior. It is deduced that T296 is involved in the 1,6-ring closure (Fig. 3b). 
The variant T296S retains the cyclization ability suggesting that the hydroxyl group is involved. In addition, this 
residue is conserved as threonine or serine in several terpene synthases except for β-farnesene synthase which 
produces an acyclic product and germacrene A synthase which lacks 1,6-ring closure. However, T296A also 
retains the cyclization ability which indicates that the hydroxyl group is not necessary. As for 1,10-ring closure, 
variants G400A, G439A, L515A, L515G, L515C, L515S and L515T accumulated more α-bisabolol compared to 
the wild type indicating impaired 1,10-cyclization. This suggests that residues G400, G439 and L515 play a role in 
the success of the 1,10-ring closure.
Determination of the active site base of ADS. The active sites of terpene synthases must possess a base that 
mediates the series of deprotonations and reprotonations including the final deprotonation to yield the major 
product. In the ADS model, H392 and H448 are two apparent basic residues in the active site (Fig. 3d). The imi-
dazole side chain of these histidines can act as the functional active site base. However, the positioning of these 
residues with respect to the substrate in the model proves difficult to perform the deprotonations. In addition, 
most variants of H392 and H448 retained their catalytic activity as proven by the mutability landscape of ADS 
(Fig. 2a and b). Hence, H392 and H448 can be excluded as the active site base. Researching through literature, a 
less orthodox possibility arises where a tryptophan residue (W273) has been previously reported as the active site 
base of 5-epi-aristolochene synthase30,31. Within the active site of ADS, W271 corresponds to W273 of 5-EAS. 
Thus, we suggest that W271 can perform the same role in ADS and act as the active site base. As shown in Fig. 3d, 
the final carbocation possesses a positive charge at C11 which increases the acidity of the proton at C12 that is 
directed towards W271. This proton can now be removed by W271 producing a positive arenium ion (WH+) and 
the final major product amorpha-4,11-diene. The fact that W271 can act as the active site base is corroborated 
by the observed loss of activity of all variants, aromatic or non-aromatic, of this residue similar to 5-EAS and the 
tryptophan-271 residue is conserved in several monoterpene and sesquiterpene synthases as shown in Fig. 2c.
Residues responsible for regioselective deprotonation to produce amorpha-4,11-diene. Residue T399 was reported 
to be responsible for regioselective deprotonation to produce amorpha-4,11-diene as the major product instead 
of amorpha-4,7-diene35,36. This was confirmed by loss of activity of T399P, T399M, T399F, T399R, T399K, T399E 
and T399Q variants or the increase in the level of amorpha-4,7-diene by T399A, T399I, T399G, T399V and 
T399N variants indicating loss of regioselective deprotonation. The only variant that retained the production 
of amorpha-4,11-diene as the major product is T399S indicating the involvement of the hydroxyl group in this 
process, which is further substantiated by the conservation of this residue as threonine or serine in several terpene 
synthases (Fig. 2c).
Enhanced catalytic activity of ADS. In the mutability landscapes of ADS, comparison of V (RLUs/sec or 
amorphadiene peak area/sec) of each variant with the wild type showed hot spots with improved catalytic activity 
(Fig. 2a and b). In addition, the product profile of such variants was evaluated to ensure it is similar to that of the 
wild type (Fig. S7). Some variants of residues Q518, H392, H448, K449, V396, T399 and G439 showed up to five 
fold increase in catalytic activity compared to wild type. Position H448 had the most impact on catalytic activity 
where 15 of the produced variants showed different degrees of improved activity compared to the wild type. 
H448A displayed the highest increase in catalytic activity where it showed, in both bioluminescent and GC-MS 
assays, around 5-fold increase in catalytic rate of reaction. Variants H448F and H448C displayed 4-fold increase 
in activity, H448N, H448S and H448Q exhibited approximately 3-fold increase while H448G, H448V, H448M, 
H448R and H448T showed around 2-fold increase. Also, variants H392A, H392I, H392N, V396A, V396I, G439A, 
K449M, Q518A and Q518L displayed between 3 to 4-fold increase in catalytic activity compared to wild type. 
To further improve the catalytic activity of ADS, double mutants of the variants with improved activity com-
pared to wild type were created. Four double mutants namely; T399S/H448A, T399S/H448F, T399S/V396A and 
T399S/V396I were constructed. These double mutants were screened by the bioluminescent assay to determine 
their catalytic activity along with the wild type and corresponding single mutants. However, the double mutants 
showed V close to the single mutants H448A, H448F, V396A and V396I, respectively with the variant T399S/
H448A slightly better than the single mutants. Furthermore, kinetic measurements of Km and kcat of the wild type, 
H448A, T399S and T399S/H448A were performed using GC-MS to determine the catalytic efficiency (Table 1). 
The variant H448A showed a kcat 3.5 times higher than the wild type with their Km nearly the same. The catalytic 
efficiency (kcat/Km) of H448A was improved by ~4 folds compared to the wild type. The previously reported var-
iant T399S showed similar results of nearly 2 fold increase in kcat35,36. Finally, the double mutant T399S/H448A 
improved the kcat by 5 folds compared to wild type, but at the expense of a raised Km making its catalytic efficiency 
~3 times higher.
Enzyme kcat (s−1) Km (μM) kcat/Km (s−1.M−1)
ADSWT 0.20 ± 0.007 5.47 ± 0.558 3.6 × 104
ADSH448A 0.68 ± 0.03 5.04 ± 0.753 13.5 × 104
ADST399S 0.39 ± 0.06 5.89 ± 1.278 6.6 × 104
ADST399S/H448A 1.00 ± 0.14 8.50 ± 1.605 11.8 × 104
Table 1. Steady state kinetic parameters of wild type ADS and selected variants with FPP as the substrate.
www.nature.com/scientificreports/
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Comparison of in vivo amorphadiene production levels of highly active variants and wild 
type. E. coli was used as a cell factory to compare the amount of amorpha-4,11-diene produced in vivo by 
expression of wild type ADS, H448A, T399S and T399S/H448A. These three variants, with higher Kcat, showed 
increased production levels of amorpha-4,11-diene compared to the wild type (Fig. 4). H448A (2.2 mg/L) and 
T399S (1.2 mg/L) simultaneously showed ~3 and 1.7 times higher amorphadiene production compared to the 
wild type (0.7 mg/L). The double mutant T399S/H448A (2.7 mg/L) caused ~4 fold increase in the amount of 
amorphadiene produced. The higher amorphadiene production by these three variants corroborates that the Kcat 
of ADS is rate limiting in the synthesis of artemisinin.
Discussion
With the aid of a reliable 3D model of ADS15 and the knowledge of the structure of its active site, a rational design 
of a mutability landscape of ADS has been performed. A mutant library of the sixteen active site residues was 
generated showing high diversity of amino acids and their locations in the active site. With this library we have 
identified residues involved in the catalytic mechanism and obtained variants with improved activity compared 
to the wild type. A fast, reliable assay for screening the catalytic activity of the mutant library was indispensable 
and GC-MS, the most widely used assay for the detection of volatile terpenoids and evaluation of the kinetic 
efficiency, was deployed by us for high throughput screening36,37. In addition we have tested the catalytic activity 
by measuring the amount of released PPi using the theory of a recently described colorimetric malachite green 
assay, which was confirmed to be comparable to the GC-MS and radioactive assays38. The bioluminescent assay 
has been used by us in a 96-well format allowing for rapid screening of the library. The challenge was to determine 
a good ratio between protein and FPP concentration to produce a luminescence signal that can be accurately 
detected by the plate reader. ADS concentration of 0.15 μM in combination with 50 μM FPP was found to be 
optimal. The high amount of FPP served to ensure that its concentration is above the Km of the enzyme so the 
assay would give an approximate indication about the kcat of the different variants. This assay was complementary 
to the GC-MS assay that allowed screening the whole library for product profile and selected variants for catalytic 
activity using a time point assay.
In summary, screening of the mutability landscape proved that R262 creates a region of high positive charge 
along with the magnesium ions in the active site to bind and neutralize the negative charge of the released PPi 
preventing it from interfering with the reactive carbocations. Evidence showed that R440 and K449 were not 
involved. The importance of aromatic residues (W271, Y519 and F525) for stabilization of the reactive carboca-
tions in the active site was confirmed. Residues involved in 1,6- or 1,10-ring closure were suggested. H392 and 
H448 were excluded as the active site catalytic base while W271 was suggested as a possible candidate for this role. 
Another possibility would be that a water molecule that is present in the close vicinity of the amorphenyl cation 
and W271 can act as the active site base. This will also lead to the competitive production of the alcohol amorpha-
4-en-7(11)-ol35. A supplementary video illustration of the mechanism of ADS is provided. Finally, several variants 
having the same product profile as wild type ADS showed improved catalytic activity especially variants of residue 
H448. Mutation of H448 may have improved the release of the product from the active site or contributed to the 
stabilization of the carbocations due to its location near the active site opening and its interactions with the mag-
nesiums, pyrophosphate and surrounding residues. This provided excellent candidates for mutants with higher 
catalytic efficiency than the wild type especially H448A, which showed ~4 fold increase in catalytic efficiency. 
Furthermore, T399S/H448A increased kcat by 5 times compared to wild type, but also raised the km. These variants 
are better than the reported T399S and T447S that only show 2-fold higher turnover rate (kcat). T399S/H448A 
variant is also better thanT399S/T447S that only tripled the kcat but at the expense of higher Km compared to 
wild type35,36. Hence, the double mutant T399S/H448A can be very instrumental in improving the production of 
Figure 4. Comparison of in vivo production levels of amorpha-4,11-diene in E. coli due to expression of wild 
type ADS and variants H448A, T399S and T399S/H448A. The illustrated data are an average of two separate 
experiments (n = 2).
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amorpha-4,11-diene and in turn that of artemisinin in large scale industrial fermenters where a slightly raised Km 
is not a hindrance as opposed to the advantage of the 5 fold increase in the turnover rate.
Commercial production of artemisinin suffers from fluctuation in price and availability of plants crops. This 
led to the semi-synthetic artemisinin project using yeast cells which was approved by the WHO and produced 
by Sanofi5,6. Since ADS catalyzes the first committed and rate-limiting step in artemisinin biosynthesis7,9, the 
up-regulation of ADS is considered a good strategy for improving the production of artemisinin. In the future, 
ADS variant T399S/H448A, with improved turnover rate (kcat), can be incorporated into the yeast cells to enhance 
the production of the amorphadiene with the goal of boosting the manufacturing of artemisinin. As a proof of 
concept, the amount of amorphadiene produced in E. coli due to expression of the variants and the wild type were 
compared. It can be seen that the higher the kcat of the variant, the higher the amorphadiene production compared 
to the wild type. Hence, incorporating such variants into industrial microbial strains with improved flux of the 
upper metabolic pathway will show similar increase in amorphadiene production levels compared to wild type 
at higher titers. Also, the possibility of using these variants in transgenic Artemisia annua can be explored. The 
increased availability of artemisinin will provide a chance to lower the price and increase the supply to third world 
countries. In addition, it will open the door to explore applications of artemisinin beyond antimalarial, especially 
research in combining iron and artemisinin to target cancer cells.
Methods
Creation of ADS mutant library. Residues for mutation were selected by examining the active site of the 
reported ADS model using Discovery Studio 4.5 software (Accelrys, CA, USA). A full-length cDNA encoding 
ADS (GeneBank/NCBI accession number AY006482) in the pET15b vector in frame with the N-terminal histi-
dine tag was used as the template15. The small-intelligent method20 was implemented for full randomization of 
each residue using a mixture of four pairs of complementary primers supplied by Eurofins with the degenerate 
codons NDT, VMA, ATG, and TGG at a ratio of 12:6:1:1, respectively. Quikchange method was applied to cre-
ate the library where 50 μl PCR reactions with the primer mixture were performed using Phusion high fidelity 
DNA polymerase followed by DpnI digestion and transformation into E. coli XL1-blue. The produced colonies 
per residue were sequenced by GATC Biotech. Each desired colony was separately grown in Luria−Bertani (LB) 
broth supplemented with 100 μg/ml ampicillin. All plasmids, each containing a single mutant ADS gene, were 
isolated from their corresponding cultures using the NucleoSpin 96 Plasmid Core Kit (Bioke´). Then these iso-
lated plasmids were transformed individually into chemically competent E. coli BL21 (DE3). Each E. coli BL21 
transformant retaining a pET15b vector with a unique ADS gene constituting the library was stored at −80 °C 
until further use.
ADS library expression, purification and quantitation. The E. coli BL21 (DE3) variants were inoc-
ulated into 1 ml LB medium containing 100 μg/ml ampicillin and grown overnight at 37 °C. Overnight cultures 
were diluted to OD600 of 0.05 in 15 ml auto-induction medium [phosphate buffer (pH 7.2), 2% tryptone, 0.5% 
yeast extract, 1% NaCl, 0.6% glycerol, 0.05% glucose and 0.2% lactose] supplemented with 100 μg/ml ampicil-
lin. The cultures were grown at 37 °C, 250 rpm until OD600 of 0.7. Then, incubated overnight at 20 °C, 190 rpm. 
Cells were collected by centrifugation, 10 min at 4000 rpm, 4 °C, followed by three cycles of freezing and thawing 
then resuspended in 1.5 ml lysis buffer (50 mM Tris-HCl, pH 7.5–8.0, 100 mM NaCl, 10 mM β-mercaptoethanol, 
cOmplete™ EDTA-free protease inhibitor cocktail tablet and 1 mg/ml lysozyme). Cells were lysed by incuba-
tion at 20 °C, 250 rpm for 30 min, and the soluble protein fractions were collected by centrifugation, 10 min 
at 4000 rpm. Proteins were then purified using His MultiTrap™ Fast Flow GE Healthcare 96-well plates using 
(20 mM Tris-HCl, 10 mM MgCl2, 150 mM NaCl, 1 mM DTT and 20 mM imidazole, pH 7.4–8) as binding and 
wash buffer, and elution buffer with 10% glycerol and 250 mM imidazole. To quantify the ADS concentration 
of each variant, 24 μl of each purified protein was boiled for 5 min. with 6 μl of protein sample buffer. The boiled 
samples (15 μl) were loaded on pre-cast 4–12% polyacrylamide gels (NuPAGE Novex) with MOPS buffer. Five 
wild type ADS samples (15 μl) with standard concentrations of 100, 250, 500, 750 and 1000 ng/μl were loaded on 
the gel along with the purified variants and served as calibration samples for quantification. The concentration 
of the standards was determined by the coomassie (Bradford) protein assay39. The gels were stained using the 
Coomassie-based stain InstantBlue (Expedeon Ltd) after electrophoresis (at 150V for 1 h). A digital image of the 
gel was snapped with the aid of Chemi Genius2 Bio Imaging System (Syngene, Cambridge, UK). The pictures 
of the SDS gels were used for the densitometric concentration assessment (Fig. S1). The concentrations of the 
ADS variants in the library were calculated based on their band size and intensity in the digital image of the gel, 
compared to the calibration samples by using the software GeneTools (version 4.02, Syngene). The standard cali-
bration samples were loaded on each gel to quantify only the samples on that gel.
Bioluminescent PPiLight™ inorganic pyrophosphate assay for ADS catalytic activity. Perkin 
Elmer JANUS 8-tip Varispan Automated Liquid Handling Workstation was used for high throughput screen-
ing of the library. This assay measures the amount of PPi released from the conversion of the FPP substrate to 
amorpha-4,11-diene by ADS. The released PPi converts AMP to ATP which in turn produces light through the 
enzymatic reaction of luciferase enzyme23. Reactions containing 0.15 μM ADS protein and 50 μM FPP in 10 mM 
MgCl2, 2 mM DTT, 10 mM Tris-HCl buffer (pH 7.4) were mixed with 20 μl Lonza PPiLight™ converting and 
detection reagent mixture to a final volume of 60 μl in opaque white wall flat bottom 96-well microtiter plates 
(Greiner LUMITRAC™ 600 microplates). The plates were place immediately in a preheated to 30 °C chamber of 
FLUOstar Omega Plate reader with moderate shaking and the luminescence signal was recorded continuously for 
2 hrs and reported as Relative Light Units (RLUs). The catalytic rate of reaction (V) of each variant was presented 
as RLUs/sec and compared to wild type.
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GC-MS assay for ADS catalytic activity. Perkin Elmer JANUS 8-tip Varispan Automated Liquid 
Handling Workstation was used for high throughput screening of the library. Four 0.5 ml reactions of each vari-
ant containing purified enzymes (0.038 µM) in 10 mM Tris-HCl buffer (pH 7.4), containing 10 mM MgCl2, 2 mM 
DTT, and 10 μM FPP substrate were overlaid with 200 µl hexane containing tetradecane internal standard. The 
reactions were incubated at 30 °C then stopped by addition of an equal volume of 0.2 M KOH containing 0.1 M 
EDTA at 3, 6, 9 and 12 min, respectively. Two microliters of the n-hexane extracts were analyzed in total ion scan 
using a HP-5MS (5%-Phenyl)-methylpolysiloxane column (Agilent J&W 0.25 mm inner diameter, 0.25 µm thick-
ness, 30 m length) on a Shimadzu GCMS-QP2010SE system equipped with a GC-2010 Plus high performance gas 
chromatograph. It was injected splitless onto the GC column using helium as the carrier gas. The injector temper-
ature was 250 °C; the oven initial temperature was 50 °C with an increment of 5 °C/min up to 180 °C and then up 
to 300 °C with an increase of 10 °C/ min. The solvent cut-off was 5 minutes. The peak area of amorphadiene was 
determined in each sample. A curve of amorphadiene peak area versus time was generated for the wild type and 
the variants (Fig. S4). The catalytic rate of reaction (V) of each variant presented as amorphadiene peak area/sec 
was calculated and compared to wild type.
GC-MS assay for ADS product profile. Similarly, an in-vitro GC-MS assay was conducted to determine 
the product profiles of the library. Purified enzymes (50 μg) was assayed in 0.5 mL reactions with 46 μM FPP 
substrate and incubated for 1 hour. The product profile of all samples was compared to that of reference wild type 
ADS. The products in the chromtaograms were identified by comparing their mass spectra to spectra included in 
the NIST (National Institute of Standards and Technology, Maryland, USA) and other libraries.
GC-MS assay for measuring enzyme kinetics. Similarly, a fixed concentration of purified enzyme is 
used along with a range of FPP concentration from 0 to 50 µM. Six 0.5 ml reactions of each FPP concentration, 
consisting of purified enzyme (0.03 μM wild type ADS, 0.01 μM H448A, 0.02 μM T399S and 0.01 μM T399S/
H448A) with respective FPP concentration were incubated. Reactions were stopped at 3, 5, 7, 10, 15 and 20 min, 
respectively. Using Shimadzu OPTIC multimode inlet, 100 µl of the n-hexane extracts were injected at 60 °C with 
gradient increase up to 300 °C and 25 sec. vent time onto a chromosorb liner then to the GC-MS system. The oven 
initial temperature was 50 °C with an increment of 20 °C/min up to 300 °C. β-caryophyllene was used as standard 
to determine the concentration of amorphadiene. The MS instrument was set to selected ion mode (SIM) for 
acquisition, monitoring m/z ion 189 for amorphadiene and β-caryophyllene. The chromatographic peak areas for 
amorphadiene and β-caryophyllene were determined using the integration tools in GCMSsolution 1.20 software 
(Shimadzu, Den Bosch, The Netherlands). A calibration curve of standard β-caryophyllene with concentration 
range of 0.09–10 μM was created. For quantification of amorphadiene, the peak area for each sample was cor-
rected by using the peak corresponding to the internal standard tetradecane. The amorphadiene concentration 
in each sample was calculated by applying the linear regression equation resulting from the β-caryophyllene 
calibration curve to each adjusted amorphadiene peak area. The concentration of amorphadiene was represent as 
μM β-caryophyllene equivalent40.
Production, extraction and quantification of amorpha-4,11-diene in E. coli. Overnight cultures 
of the strains with different variants were grown in 2xYT medium containing ampicillin. The following day, the 
overnight cultures were diluted to an OD600 of 0.07–0.1. The cultures were incubated for 3 h at 37 °C and 220 rpm. 
Then, induction was started by adding IPTG to a final concentration of 1 mM. The cultures were overlaid with 
100 μl dodecane containing 10 μl of 700 μM β-caryophyllene as internal standard. Then the cultures were grown 
overnight at 20 °C and 220 rpm. The next day extraction was performed by adding 200 μl hexane to the cultures 
overlaid with dodecane, followed by centrifugation for 10 min at 11000 rpm to separate the aqueous and organic 
phases. The dodecane-hexane layer was extracted for GC-MS analysis. The dodecane-hexane extracts were ana-
lyzed on an HP-5MS (5% Phenyl)-methylpolysiloxane column (Agilent J&W 0.25 mm inner diameter, 0.25 μm 
thickness, 30 m length) in a Shimadzu GCMS-QP2010SE system equipped with a 17A gas chromatograph (GC) 
and AOC-20i autoinjector. The extracts (2 μL) were injected splitless onto the GC column. The injector temper-
ature was 250 °C, and the oven initial temperature was 100 °C with an increase of 10 °C per minute up to 210 °C. 
After 210 °C was reached the temperature was raised to 280 °C with an increase of 35 °C per minute and held for 
2 min. The solvent cutoff was 4 min. The amount of amorphadiene was quantified as previously mentioned in 
literature40.
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